Articles publiés

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database

Revol B, Lapeyre-Mestre M, Fouilhé Sam-Laï N, Jouanjus E. Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database. Br J Clin Pharmacol. 2022 Jun 4. doi: 10.1111/bcp.15430. Epub ahead of print. PMID: 35665950.

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database Lire la suite »

Abuse and misuse of second-generation antipsychotics: an analysis using VigiBase TM , the World Health Organisation pharmacovigilance database

Roy S, Charreteur R, Peries M, Kheloufi F, Eiden C, Nagot N, Donnadieu-Rigole H, Micallef J, Peyrière H. Abuse and misuse of second-generation antipsychotics: an analysis using VigiBase TM , the World Health Organisation pharmacovigilance database. Br J Clin Pharmacol. 2022 May 27. doi: 10.1111/bcp.15420. Epub ahead of print. PMID: 35633029.  

Abuse and misuse of second-generation antipsychotics: an analysis using VigiBase TM , the World Health Organisation pharmacovigilance database Lire la suite »

Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années

Guerra C, Soeiro T, Lacroix C, Jouve E, Micallef J, Frauger E. Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années [Increasing methylphenidate abuse: Tracking and profiles during 13-years]. Therapie. 2022 Apr 26:S0040-5957(22)00066-X. French. doi: 10.1016/j.therap.2022.03.006. Epub ahead of print. PMID: 35599193.

Augmentation de l’abus de méthylphénidate : repérage et profils sur 13 années Lire la suite »

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels

Largeau B, Karam A, Potey C, Caous AS, Tard C, Carton L, Kuchcinski G, Gautier S, Deheul S, Bordet R. Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels. Eur J Neurol. 2022 Apr 23. doi: 10.1111/ene.15370. Epub ahead of print. PMID: 35460312.

Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels Lire la suite »

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior

Laforgue EJ, Istvan M, Schreck B, Mainguy M, Jolliet P, Grall-Bronnec M, Victorri-Vigneau C. Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior. J Clin Med. 2022 Apr 13;11(8):2176. doi: 10.3390/jcm11082176. PMID: 35456269; PMCID: PMC9032177.

Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior Lire la suite »

Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data.

Roussin A, Soeiro T, Fouque C, Jouanjus E, Frauger E, Fouilhé N, Mallaret M, Micallef J, Lapeyre-Mestre M; French Addictovigilance Network (FAN).  Br J Clin Pharmacol. 2022 Mar 22. doi: 10.1111/bcp.15323. Epub ahead of print. PMID: 35318713.

Increase of high-risk tramadol use and harmful consequences in France from 2013-2018: evidence from the triangulation of addictovigilance data. Lire la suite »

Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F)

Delage N, Cantagrel N, Delorme J, Pereira B, Dualé C, Bertin C, Chenaf C, Kerckhove N, Laporte C, Picard P, Roussin A, Authier N. Can J Anaesth. 2022 Feb 28. English. doi: 10.1007/s12630-022-02210-7. Epub ahead of print. PMID: 35229249.

Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F) Lire la suite »

Retour en haut